FREMONT, Calif., Feb. 25, 2025 /PRNewswire/ — Ultima Genomics, Inc., developer of the UG100™ next-generation sequencing (NGS) platform, today announced expanded global access to high-quality, low-cost ...
A committee-supported project or activity that has been completed and for which output dissemination has begun. Its committee has been disbanded and closeout procedures are underway. A planning ...
In collaboration with the 29 th International Conference on Research in Computational Molecular Biology (RECOMB), Genome Research publishes a collection of novel computational methods and their ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Arima Genomics, Inc., a company leveraging 3D genomics to reveal actionable insights that will empower researchers and clinicians to improve human health, today ...
SAN DIEGO--(BUSINESS WIRE)--Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, today announced a collaboration and co-marketing partnership with Jumpcode Genomics ...
FREMONT, Calif. and HOUSTON, Aug. 19, 2025 /PRNewswire/ -- Ultima Genomics, Inc., developer of the UG 100™ next-generation sequencing (NGS) platform, and Gene by Gene, a leading global provider of ...
April 25 marks an annual celebratory occasion for the genomics world: DNA Day. The designation commemorates the remarkable progress the industry has collectively made in our understanding of genomics ...
SAN DIEGO--(BUSINESS WIRE)-- Arima Genomics, Inc., the leader in 3D genomics, today announced the close of its $7 million Series B Preferred Stock financing round. New investors Genetron Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results